Daytrana® (methylphenidate transdermal system), developed and manufactured by Noven, is the first and only transdermal medication approved to treat the symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 to 17 years old. The Daytrana® patch is available in four dosage strengths (10mg/9 hours (1.1 mg/hr), 15mg/9 hours (1.6 mg/hr), 20mg/9 hours (2.2 mg/hr), 30mg/9 hours (3.3 mg/hr). Noven markets and sells Daytrana® through the CNS unit of its specialty pharmaceuticals subsidiary, Noven Therapeutics, LLC.
For more information, please visit www.daytrana.com.
NEED HELP FINDING DAYTRANA®?
Noven is working diligently to improve product availability, but intermittent spot retail shortages of Daytrana® may continue for the remainder of 2016. The Pharmacy Locator Service (1-800-420-2719) can potentially identify a pharmacy that might have Daytrana® in stock. If you are unable to find a pharmacy that has Daytrana® in stock, please contact your health care provider.
The Daytrana® patch contains a prescription central nervous system (brain) stimulant medicine used to treat ADHD in children and adolescents 6 to 17 years old. Use of the Daytrana® patch may help increase attention and decrease impulsive and hyperactive behavior. The Daytrana® patch should be used as a part of a total treatment program for ADHD that may include counseling or other therapies.
Daytrana® is a controlled substance (CII) because it can be abused or lead to dependence. Keep Daytrana® in a safe place to protect it from theft. Selling or giving away Daytrana® may harm others and is against the law. Tell the prescribing doctor if your child has ever abused or been dependent on alcohol, prescription medicines or street drugs.
The Daytrana® patch should not be used if your child has been diagnosed as very anxious, tense, or agitated; has an eye problem called glaucoma; has tics (repeated movements or sounds that cannot be controlled); has a diagnosis or family history of Tourette's syndrome; is taking a monoamine oxidase inhibitor (MAOI) medicine or has discontinued an MAOI medicine in the last 2 weeks; or is allergic to methylphenidate, acrylic adhesive, or silicone adhesive.
Serious heart problems have been reported with the Daytrana® patch or other stimulant medicines including:
Tell the doctor if your child or a family member has any heart problems, heart defects, or increased blood pressure and heart rate. Remove the Daytrana® patch and call the doctor right away if your child has any signs of heart problems such as chest pain, shortness of breath, or fainting while using Daytrana®. Before you start using Daytrana®, tell your doctor if you have circulation problems in fingers or toes. Tell your doctor if you have or your child has numbness, pain, skin color change, or sensitivity to temperature in your fingers or toes. Call your doctor right away if you have or your child has any signs of unexplained wounds appearing on fingers or toes while taking Daytrana®.
Serious mental (psychiatric) problems have been reported with the Daytrana® patch or other stimulant medicines including:
Tell the doctor about any mental problems your child or family members have experienced including suicide or depression, bipolar illness, mania, or psychosis. Call the doctor right away if your child has any new or worsening mental symptoms or problems while using the Daytrana patch. Tell your doctor if you, your child, or a family member has a history of vitiligo.
Be sure to tell the doctor if your child is pregnant or breast feeding.
Serious side effects such as seizures (this usually happens in children with a history of seizures), painful and prolonged erections (priapism), slowing of growth (weight and height), persistent loss of skin color (chemical leukoderma) and eyesight changes or blurred vision have been reported with the Daytrana® patch. Because of the potential for lasting damage, seek medical help immediately if you or your child develops priapism. Your child should have their height, weight, and blood work checked while using the Daytrana® patch and the doctor may stop treatment if a problem is found during these check-ups. Allergic skin rash may occur. Stop using the Daytrana® patch and see the doctor right away if swelling, bumps, or blisters happen at or around the site where the patch is applied. If the patch is worn longer than 9 hours in a day, or if more than 1 patch is worn at a time, too much medicine has been applied. Avoid exposing the Daytrana® patch to direct external heat sources such as hair dryers, heating pads, electric blankets, heated water beds, or other heat sources while wearing the patch. Heating the patch could cause too much medicine to pass into your child's body and cause serious side effects.
The most common side effects seen while using the Daytrana® patch include skin problems (redness, small bumps, itching) where the patch is applied, poor appetite, nausea, vomiting, stomach pain, weight loss, tics, trouble sleeping, mood swings, and dizziness.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
For patient, physician and pharmacist inquiries regarding Daytrana®, please contact: